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rabbit was induced by using a model proposed by Hester (1987), Melena (1997), just because 
using other proposed methods found in literature can block the filtering device. The 
hypertension was obtained by a local subconjunctival injection of 0,7ml betamethasone 
suspension in one eye. The procedure was repeated for 3 weeks. The injections were done in 
aseptic conditions under local anesthesia. It was observed the elevated IOP after the last 
injection with corticosteroid. After obtained ocular hypertension, it was performed the filtration 
surgery by implantation of a new design model of antiglaucoma shunt and it was monitoring 
the IOP postoperative and the ocular status.  
Conclusions. We aim to highlight the possibility of using a new device for glaucoma filtration 
surgery, its influence on IOP and ocular surface. Good results in the experimental 
implementation of this way of glaucoma surgery seem to be the most important step in treating 
this pathology except the classic trabeculectomy, which has also limitations.  
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Background. Myasthenia gravis (MG) is an autoimmune disease in which the patients’ 
immune system, through the antibodies, attack the nicotinic acetylcholine receptors located on 
the postsynaptic neuro-muscular junction, resulting in fatigability and weakness of skeletal 
muscles. If weakness is limited only to the extrinsic ocular muscles and to the levator palpebrae 
superioris, the disease is called Ocular MG. However, ocular muscle weakness can be a debut 
symptom in the Generalized form of the MG (GMG) as well. Thus, the surveillance of the 
patient in early stage is essential, particularly during first 2 years, as most of them develop 
GMG within this period.    
Case report.  A 52-year-old man was admitted at the Neurology Department with weakness 
in the upper eyelids, expressed through the reduction of the palpebral fissures, gradually 
through the first half of the day (blepharoptosis), incapacity to fully open the eyes, moderate 
diffuse headache, anxiety and difficulty in falling asleep. He presented similar symptoms for 
about 15 years. In 2009, the patient did an electroneurography of the median nerve, where a 
positive decrement was registered and the diagnosis of Ocular Myasthenia Gravis was first 
mentioned. The patient was given treatment with Ipidacrinum, with no positive dynamics. After 
almost 10 years, in 2017, the patient’s general condition worsened, he was not capable anymore 
of driving, his quality of life has decreased and he addressed the neurologist again. He is tested 
on the serum antibodies. Both the Anti-acetylcholine receptor (anti-AchR) antibodies and the 
Anti-muscle-specific tyrosine kinase (anti-MuSK) antibodies were found slightly positive 
(AchR Ab – 0.25 [normal value <0.2&#93;; MuSK Ab – 0.05 [normal value <0.05&#93;). 
After several months, the anti-AchR Ab raised up to 0.52nmol/L. The Tensilon (Neostigmine) 
test was performed and revealed only a week positive outcome: after administrating 1ml 
Neostigmine i/m, the palpebral fissures measured 4 mm, compared to 3 mm before the 
injection. Based on these borderline results, we confirmed the Ocular Myasthenia Gravis form 
as diagnosis and we added Prednisolone to the treatment, with moderate improvement of the 
symptoms.    
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Conclusions. Based on the described evidence, the increase in the concentration of the 
antibodies against acetylcholine receptors correlate with the development of Myasthenia 
gravis. The worsening of the patient’s symptoms may be associated with inefficient plan of 
treatment. Being symptomatic despite the treatment with a cholinesterase inhibitor 
(Neuromedin) demands adding a glucocorticoid drug (ex. Prednisolone).    
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muscle-specific tyrosine kinase (anti-MuSK) antibodies   
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Background. Methanol toxicity is poisoning from methanol. Symptoms include a decreased 
level of consciousness, poor coordonation, vomiting, abdominal pain, and a specific smell on 
the breath. It is characterized by acute loss of visual function around 12 to 24 hours after 
ingestion of methanol. The ocular manifestations of acute methyl alcohol intoxication include 
decreased visual acuity, areflexic mydriasis, optic nerve atrophy with possibility of complete 
blindness. Treatment of methanol poisoning include fomepizole or ethanol.  
Case report. Patient P., 40 years old. He had addressed to Emergy Department 10 hours after 
ingestion of methanol. He presented with blurred vision and fatigue. He had no previous history 
of ophthalmologic problems. The VA was 0,01 in both eyes. Intraocular pressure in both eyes 
were normal. By ophthalmoscopy, optic disc hyperemia and lack of Optic Nerve Head border. 
Toxicologist established diagnosis of methanol poisoning after 1 hour. The patient was treated 
with Dexamethasone 32 mg and cardiac drugs. Despite all treatment that was administered, 
patient died in 2 hours after he was addressed to hospital.   
Conclusions. Optic neuropathy is a severe diagnosis that should be established in time. Early 
treatment instituted by a serious medical team is essential to avoid complications.  
Key words: optic neuropathy, methanol poisoning, ocular impairment. 
 
 
SURGERY SECTION 
 
DEPARTMENT OF SURGERY NO.1 NICOLAE ANESTIADI 
 
51. GALLSTONE ILEUS: IMAGING DIAGNOSIS   
Author: Nicoleta Pricop  
Co-authors: Corina Scerbatiuc-Condur, V.Gheorghiţa  
Scientific adviser: Igor Mishin, MD, PhD, Professor, Department of Surgery no.1 Nicolae 
Anestiadi and Laboratory of Hepato-Pancreato-Biliary Surgery, Nicolae Testemitanu State 
University of Medicine and Pharmacy, Chisinau, Republic of Moldova 
 
Introduction.  Gallstone ileus (GI) is a rare complication of biliary lithiasis, being registered 
in about 4% as a potential cause of intestinal obstruction (IO). GI is imagistically characterized 
